John C.K. Milligan's most recent trade in TherapeuticsMD Inc was a trade of 103,500 Common Stock done . Disclosure was reported to the exchange on May 10, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TherapeuticsMD Inc | John C.K. Milligan | Secretary/CEO of subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 103,500 | 1,796,955 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | John C.K. Milligan | Secretary/CEO of subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 103,500 | 207,000 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | John C.K. Milligan | Secretary/CEO of subsidiary | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 10 May 2021 | 44,252 | 1,752,703 (0%) | 0% | 1.0 | 46,022 | Common Stock |